Palo Alto, California – April 17, 2025: RISA Labs has raised a $3.5M funding spherical to assist healthcare organizations get rid of one of the persistent obstacles to well timed most cancers care: prior authorization delays. RISA Labs has already confirmed that quicker care is feasible by dramatically decreasing handbook workflows and administrative burden.
The seed was led by Binny Bansal (Flipkart co-founder) with participation from Oncology Ventures, Basic Catalyst, z21 Ventures, ODD BIRD VC, and Ashish Gupta. The capital will speed up deployments within the subsequent 100 most cancers facilities throughout the nation throughout the subsequent two years.
“Prior authorizations stay one of many least automated elements of our healthcare system,” stated Ben Freeberg, Managing Accomplice at Oncology Ventures. “In oncology, the stakes are increased. 70% of most cancers sufferers expertise delays in care due to prior authorization necessities. In 33% of these instances, the delay is one month—a time window that may improve the chance of dying by 13 % in sure most cancers varieties. The present system isn’t simply inefficient – it’s harmful.”
RISA’s platform—Enterprise Working System as a Service (BOSS) – is just not one other automation bot or AI assistant. It’s a full-stack orchestration engine constructed for the vertical complexity of healthcare, As an alternative of counting on people to push paperwork or brittle bots that break when methods change, BOSS decomposes complicated workflows into micro-tasks, then delegates them to a community of clever brokers—LLMs, digital twins, and reinforcement learners, extending throughout an establishment’s complete software program stack. This enables BOSS to create a parallel digital workforce, working on behalf of groups and alongside them. A 1,000-person establishment can perform like a 2,000-person one in a single day, with digital brokers making up half the workforce.
“We’ve had Home windows, we’ve had Linux, we’ve had Mac, every OS helped people extract extra from machines. However now, we’re drowning in software program. There’s an excessive amount of of it, and a scarcity of expert labor to function it. Software program that was speculated to get work executed has turn into work itself,” Kshitij Jaggi, co-founder and CEO of RISA Labs provides. “BOSS is an AI OS designed for the post-ChatGPT period : the place work is not about studying instruments, however merely expressing intent.”
At a number one US most cancers middle, BOSS diminished prior authorization instances from half-hour to beneath 5. In just some months, it processed over $1 million in medicines, freed up 80 % of workers time, and minimize administrative prices by 66 %.
“Most cancers care is time delicate. Each delay in remedy can have an effect on outcomes. Prior authorizations proceed to sluggish us down. What RISA is constructing is not only good expertise. It removes obstacles so our groups can transfer quicker and keep targeted on what issues most: caring for sufferers,” stated Dr. Jeffrey Vacirca, CEO of New York Most cancers and Blood Specialists.
Based mostly in Silicon Valley, RISA was based by IIT Kanpur alumni and serial founders, Kshitij Jaggi (CEO) and Kumar Shivang (CTO), longtime pals for over a decade who beforehand constructed and scaled City Well being. Their frustration with fragmented, sluggish, and error-prone healthcare workflows throughout that journey impressed the duo to take a systems-first method, main them to develop a foundational AI working system that may simulate, perceive, and orchestrate complete institutional workflows from finish to finish.
“BOSS is low-entropy system design to convey move state in system-2 considering for LLMs; it goals to maximise AI brokers’ usefulness for vital issues like oncology operations,” stated Kumar Shivang, co-founder & CTO of RISA. “Its orchestration layer then turns that intelligence into exact, real-time execution with integrations with methods of document like Flatiron Well being’s EMR.”
RISA’s founding workforce first explored these ideas via analysis, co-authoring ‘Digital Twin Ecosystem in Oncology Scientific Operations’—an early effort to examine smarter, AI-driven most cancers care workflows. This foundational work laid the conceptual groundwork that later translated into tangible enhancements in real-world oncology operations.
RISA’s platform alerts a broader shift in enterprise AI. “As AI brokers unbundle the $4.6 trillion providers business, RISA’s BOSS leads the way in which—confirmed in oncology and constructed to scale,” stated Binny Bansal, co-founder —of Flipkart and lead investor.
Trying forward, RISA plans to increase throughout a number of nodes throughout the oncology ecosystem, positioning itself because the AI transformation associate for each operational and medical workflows. This consists of enabling coordination and intelligence throughout suppliers, life sciences organizations, and different stakeholders all through the journey of a drug – extending the corporate’s long run imaginative and prescient to constructing a unified layer for AI-driven orchestration in oncology.
